p27kip protein levels and E2F activity are targets of Cot kinase during G1 phase progression in T cells

The Journal of Immunology : Official Journal of the American Association of Immunologists
A Velasco-Sampayo, S Alemany

Abstract

Cot/Tpl-2 kinase, homologous to members of mitogen-activated protein kinase kinase kinase, was initially discovered by its capacity to promote cell transformation. Cot/Tpl-2 mRNA levels are increased during G(0) to G(1) phase progression in T lymphocytes, suggesting a role for this kinase later on in the cell cycle. The IL-2-dependent CTLL-2 cells were used to investigate the role of Cot kinase in G(1) to S phase transition. Transient expression of Cot kinase in CTLL-2 cells increases DNA synthesis triggered by IL-2 and the transient expression of a dominant negative form of Cot kinase in CTLL-2 markedly reduces the DNA synthesis triggered by this cytokine. Cell cycle analysis of synchronized CTLL-2 stabling overexpressing Cot kinase indicates that this kinase contributes to the passage to S and G(2)-M phases of the cell cycle. Cot kinase reduces the levels of the cyclin kinase inhibitor p27(kip), whereas bcl-x(L) expression is unaffected. Cot kinase also increases E2F transcriptional activity in a phosphatidylinositol 3 kinase-independent way and acts in synergy with this kinase. These data give evidence, for the first time, of the regulation of different G(1) progression events by Cot kinase.

References

Jul 14, 1977·Nature·S Gillis, K A Smith
Jan 1, 1995·Annual Review of Immunology·J N IhleO Silvennoinen
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C PatriotisP N Tsichlis
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·C PatriotisP N Tsichlis
Mar 15, 1997·Genes & Development·J D CeciN G Copeland
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·N N AhmedP N Tsichlis
Apr 8, 1998·Current Opinion in Genetics & Development·K Helin
Apr 30, 1998·Current Opinion in Cell Biology·J Downward
Jun 11, 1998·The Journal of Biological Chemistry·A BallesterS Alemany
Feb 23, 1999·The American Journal of Pathology·R V LloydB W Scheithauer
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts
Jul 27, 1999·The Journal of Biological Chemistry·H Gille, J Downward
Sep 22, 1999·Oncogene·G SourvinosD A Spandidos
Sep 24, 1999·European Journal of Pharmacology·C CamposS Alemany

❮ Previous
Next ❯

Citations

Oct 1, 2003·Molecular and Cellular Biology·Maria Luisa GándaraSusana Alemany
Feb 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jeonghee Cho, Philip N Tsichlis
Feb 28, 2015·International Journal of Molecular Sciences·Hye Won LeeDo-Hyun Nam
Jun 24, 2008·Cellular Signalling·Cristina RodríguezSusana Alemany
Dec 26, 2003·The American Journal of Pathology·Katerina PolitiArgiris Efstratiadis

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2021 Meta ULC. All rights reserved